‘I’m A Scientific Cultivator’: Meet Ignacio Peralta, The First Cannabis Cultivation Post Doctorate In Argentina
By Hernán Panessi, Via El Planteo.
Avicanna To Bring Its CBD-Based Drugs To Latin America Via Chilean Pharma Partner
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) revealed Friday that it has partnered with Chile's Knop Laboratorios S.A.
Avicanna Reports Master Supply Deal With Knop Labs For Range OF Cannabinoid-Based Active Pharma Ingredients For Manufacturing, Commercialization, No Terms Disclosed
Expansion and fortification of relationship since 2020 with established pharmaceutical company in Chile
Supply of Avicanna’s active pharmaceutical ingredients for existing commercial and pipeline of pharmaceutical
Cannabis Movers & Shakers: Aurora Bolsters Management, Curaleaf Names New Pres, Verano & Avicanna’s New Appointments
Aurora Announces Changes To Management Team
Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table
This article was originally published on The Bluntness, and appears here with permission.
As more big business movers and shakers appear to be ratcheting up their incursions into the cannabis industry, industry advocates are stepping up their defense.
Avicanna Debuts CBD Derma-Cosmetics Pura H&W In US Via Deal With Red White & Bloom
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Wednesday the
Avicanna & Al Harrington’s CBD Wellness Launch New Sports Recovery-Based CBD Brand re+PLAY
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) announced on Monday the launch of re+PLAY sports recovery-based CBD brand through a partnership with Harrington Wellness, founded by NBA veteran Al Harrington.
Avicanna’s Shares Drop On Patent Application For Oral Cannabinoid Technology For Neurological Disorders
Cannabis-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE:0NN) revealed Monday that it has filed a provisional patent application in the United States Patent and Trademark Office for novel technology for the treatment of various neurological diseases and disorders
Avicanna To Bring Its Cannabinoid-Based Drugs To Argentina Via ‘Established’ Pharma Partner
Cannabinoid-focused biopharmaceutical company Avicanna Inc.
Lab-Grown Cannabinoids: Is The Cannabis Market Ready?
Original publication date: November 9, 2020 4:30 pm